Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-14

FDA Approved: DOCETAXEL — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s original application for generic docetaxel. Docetaxel is a chemotherapy agent used to treat multiple cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)

Snippet

ORIG AP for DOCETAXEL (DOCETAXEL)